This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC Specialty Journals
JACC: CardioOncology – Atrial Fibrillation Incidence Associated with exposure to Anticancer Drugs used as Monotherapy in Clinical Trials
Released: Apr 18, 2023
Commentary by Dr. Daniel Addison
JACC: CardioOncology – Atrial Fibrillation Incidence Associated with exposure to Anticancer Drugs used as Monotherapy in Clinical Trials
00:00:00
